Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 2
1989 3
1990 2
1991 2
1992 2
1993 1
1994 1
1995 3
1996 2
1997 2
2008 1
2010 2
2011 2
2012 1
2013 1
2015 1
2016 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Group A streptococcal bacteremia. A 10-year prospective study.
Bernaldo de Quirós JC, Moreno S, Cercenado E, Diaz D, Berenguer J, Miralles P, Catalán P, Bouza E. Bernaldo de Quirós JC, et al. Medicine (Baltimore). 1997 Jul;76(4):238-48. doi: 10.1097/00005792-199707000-00002. Medicine (Baltimore). 1997. PMID: 9279330 Free article. Review.
[Fitz-Hugh-Curtis syndrome in subacute/acute phase].
Demelo-Rodríguez P, González-Munera A, Tejerina F, Bernaldo De Quirós JC. Demelo-Rodríguez P, et al. Among authors: bernaldo de quiros jc. Rev Clin Esp (Barc). 2013 Jun-Jul;213(5):e49. doi: 10.1016/j.rce.2013.01.004. Epub 2013 Mar 14. Rev Clin Esp (Barc). 2013. PMID: 23498879 Spanish. No abstract available.
[Group A beta-hemolytic Streptococcus bacteremia].
Bernaldo de Quirós JC, Rodríguez-Créixems M, Cosín J, Cercenado E, Wilhelmi I, Bouza E. Bernaldo de Quirós JC, et al. Med Clin (Barc). 1987 Jan 10;88(1):9-12. Med Clin (Barc). 1987. PMID: 3546974 Spanish. No abstract available.
Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
García F, Bernaldo de Quirós JC, Gómez CE, Perdiguero B, Nájera JL, Jiménez V, García-Arriaza J, Guardo AC, Pérez I, Díaz-Brito V, Conde MS, González N, Alvarez A, Alcamí J, Jiménez JL, Pich J, Arnaiz JA, Maleno MJ, León A, Muñoz-Fernández MA, Liljeström P, Weber J, Pantaleo G, Gatell JM, Plana M, Esteban M. García F, et al. Among authors: bernaldo de quiros jc. Vaccine. 2011 Oct 26;29(46):8309-16. doi: 10.1016/j.vaccine.2011.08.098. Epub 2011 Sep 9. Vaccine. 2011. PMID: 21907749 Clinical Trial.
32 results